COVID-19 Impact on Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 126 pages | ID: C2A2DFCE095FEN
QYResearch

Abstracts

This report focuses on the global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystic Fibrosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Vertex Pharmaceuticals
• F. Hoffmann-La Roche
• AbbVie
• Gilead Sciences
• Novartis
• AstraZeneca
• Bayer
• Celtaxsys
• Pharmaxis
• ProQR Therapeutics
• PTC Therapeutics
• Alcresta Therapeutics
• Insmed Incorporated
• Savara
• Cyclacel Pharmaceuticals
• Vectura
• Allergan

Market segment by Type, the product can be split into

• CFTR
• Mucolytics
• PERT
• Anti-infectives
• Bronchodilators

Market segment by Application, split into

• Hospitals
• Clinics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Cystic Fibrosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cystic Fibrosis Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CFTR
  1.4.3 Mucolytics
  1.4.4 PERT
  1.4.5 Anti-infectives
  1.4.6 Bronchodilators
1.5 Market by Application
  1.5.1 Global Cystic Fibrosis Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
1.6 Coronavirus Disease 2019 (Covid-19): Cystic Fibrosis Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cystic Fibrosis Therapeutics Industry
    1.6.1.1 Cystic Fibrosis Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cystic Fibrosis Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cystic Fibrosis Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cystic Fibrosis Therapeutics Market Perspective (2015-2026)
2.2 Cystic Fibrosis Therapeutics Growth Trends by Regions
  2.2.1 Cystic Fibrosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cystic Fibrosis Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cystic Fibrosis Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Cystic Fibrosis Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cystic Fibrosis Therapeutics Players by Market Size
  3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cystic Fibrosis Therapeutics Market Concentration Ratio
  3.2.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2019
3.3 Cystic Fibrosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
3.5 Date of Enter into Cystic Fibrosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2021-2026)

5 CYSTIC FIBROSIS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cystic Fibrosis Therapeutics Market Size (2015-2020)
6.2 Cystic Fibrosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cystic Fibrosis Therapeutics Market Size (2015-2020)
7.2 Cystic Fibrosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Cystic Fibrosis Therapeutics Market Size (2015-2020)
8.2 Cystic Fibrosis Therapeutics Key Players in China (2019-2020)
8.3 China Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
8.4 China Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cystic Fibrosis Therapeutics Market Size (2015-2020)
9.2 Cystic Fibrosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2015-2020)
10.2 Cystic Fibrosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Cystic Fibrosis Therapeutics Market Size (2015-2020)
11.2 Cystic Fibrosis Therapeutics Key Players in India (2019-2020)
11.3 India Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
11.4 India Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cystic Fibrosis Therapeutics Market Size (2015-2020)
12.2 Cystic Fibrosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Vertex Pharmaceuticals
  13.1.1 Vertex Pharmaceuticals Company Details
  13.1.2 Vertex Pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
  13.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020))
  13.1.5 Vertex Pharmaceuticals Recent Development
13.2 F. Hoffmann-La Roche
  13.2.1 F. Hoffmann-La Roche Company Details
  13.2.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction
  13.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.2.5 F. Hoffmann-La Roche Recent Development
13.3 AbbVie
  13.3.1 AbbVie Company Details
  13.3.2 AbbVie Business Overview and Its Total Revenue
  13.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction
  13.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.3.5 AbbVie Recent Development
13.4 Gilead Sciences
  13.4.1 Gilead Sciences Company Details
  13.4.2 Gilead Sciences Business Overview and Its Total Revenue
  13.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction
  13.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.4.5 Gilead Sciences Recent Development
13.5 Novartis
  13.5.1 Novartis Company Details
  13.5.2 Novartis Business Overview and Its Total Revenue
  13.5.3 Novartis Cystic Fibrosis Therapeutics Introduction
  13.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.5.5 Novartis Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction
  13.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 Bayer
  13.7.1 Bayer Company Details
  13.7.2 Bayer Business Overview and Its Total Revenue
  13.7.3 Bayer Cystic Fibrosis Therapeutics Introduction
  13.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.7.5 Bayer Recent Development
13.8 Celtaxsys
  13.8.1 Celtaxsys Company Details
  13.8.2 Celtaxsys Business Overview and Its Total Revenue
  13.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction
  13.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.8.5 Celtaxsys Recent Development
13.9 Pharmaxis
  13.9.1 Pharmaxis Company Details
  13.9.2 Pharmaxis Business Overview and Its Total Revenue
  13.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction
  13.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.9.5 Pharmaxis Recent Development
13.10 ProQR Therapeutics
  13.10.1 ProQR Therapeutics Company Details
  13.10.2 ProQR Therapeutics Business Overview and Its Total Revenue
  13.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction
  13.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  13.10.5 ProQR Therapeutics Recent Development
13.11 PTC Therapeutics
  10.11.1 PTC Therapeutics Company Details
  10.11.2 PTC Therapeutics Business Overview and Its Total Revenue
  10.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction
  10.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.11.5 PTC Therapeutics Recent Development
13.12 Alcresta Therapeutics
  10.12.1 Alcresta Therapeutics Company Details
  10.12.2 Alcresta Therapeutics Business Overview and Its Total Revenue
  10.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction
  10.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.12.5 Alcresta Therapeutics Recent Development
13.13 Insmed Incorporated
  10.13.1 Insmed Incorporated Company Details
  10.13.2 Insmed Incorporated Business Overview and Its Total Revenue
  10.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction
  10.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.13.5 Insmed Incorporated Recent Development
13.14 Savara
  10.14.1 Savara Company Details
  10.14.2 Savara Business Overview and Its Total Revenue
  10.14.3 Savara Cystic Fibrosis Therapeutics Introduction
  10.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.14.5 Savara Recent Development
13.15 Cyclacel Pharmaceuticals
  10.15.1 Cyclacel Pharmaceuticals Company Details
  10.15.2 Cyclacel Pharmaceuticals Business Overview and Its Total Revenue
  10.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
  10.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.15.5 Cyclacel Pharmaceuticals Recent Development
13.16 Vectura
  10.16.1 Vectura Company Details
  10.16.2 Vectura Business Overview and Its Total Revenue
  10.16.3 Vectura Cystic Fibrosis Therapeutics Introduction
  10.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.16.5 Vectura Recent Development
13.17 Allergan
  10.17.1 Allergan Company Details
  10.17.2 Allergan Business Overview and Its Total Revenue
  10.17.3 Allergan Cystic Fibrosis Therapeutics Introduction
  10.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  10.17.5 Allergan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cystic Fibrosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue
Table 3. Ranking of Global Top Cystic Fibrosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CFTR
Table 6. Key Players of Mucolytics
Table 7. Key Players of PERT
Table 8. Key Players of Anti-infectives
Table 9. Key Players of Bronchodilators
Table 10. COVID-19 Impact Global Market: (Four Cystic Fibrosis Therapeutics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Cystic Fibrosis Therapeutics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Cystic Fibrosis Therapeutics Players to Combat Covid-19 Impact
Table 15. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Cystic Fibrosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Cystic Fibrosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Cystic Fibrosis Therapeutics Market Share by Regions (2015-2020)
Table 19. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Cystic Fibrosis Therapeutics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Cystic Fibrosis Therapeutics Market Growth Strategy
Table 25. Main Points Interviewed from Key Cystic Fibrosis Therapeutics Players
Table 26. Global Cystic Fibrosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Cystic Fibrosis Therapeutics Market Share by Players (2015-2020)
Table 28. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Therapeutics as of 2019)
Table 29. Global Cystic Fibrosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Cystic Fibrosis Therapeutics Product Solution and Service
Table 32. Date of Enter into Cystic Fibrosis Therapeutics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. Global Cystic Fibrosis Therapeutics Market Size Share by Type (2015-2020)
Table 36. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 37. Global Cystic Fibrosis Therapeutics Market Size Share by Application (2015-2020)
Table 38. Global Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. Global Cystic Fibrosis Therapeutics Market Size Share by Application (2021-2026)
Table 40. North America Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 42. North America Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. North America Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 44. North America Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. North America Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 46. Europe Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 48. Europe Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 50. Europe Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 52. China Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 54. China Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. China Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 56. China Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. China Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 58. Japan Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 60. Japan Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 62. Japan Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 66. Southeast Asia Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 68. Southeast Asia Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 70. India Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 72. India Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. India Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 74. India Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. India Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Cystic Fibrosis Therapeutics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Cystic Fibrosis Therapeutics Market Share (2019-2020)
Table 78. Central & South America Cystic Fibrosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Cystic Fibrosis Therapeutics Market Share by Type (2015-2020)
Table 80. Central & South America Cystic Fibrosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Cystic Fibrosis Therapeutics Market Share by Application (2015-2020)
Table 82. Vertex Pharmaceuticals Company Details
Table 83. Vertex Pharmaceuticals Business Overview
Table 84. Vertex Pharmaceuticals Product
Table 85. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 86. Vertex Pharmaceuticals Recent Development
Table 87. F. Hoffmann-La Roche Company Details
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Product
Table 90. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 91. F. Hoffmann-La Roche Recent Development
Table 92. AbbVie Company Details
Table 93. AbbVie Business Overview
Table 94. AbbVie Product
Table 95. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 96. AbbVie Recent Development
Table 97. Gilead Sciences Company Details
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Product
Table 100. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 101. Gilead Sciences Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Product
Table 105. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 106. Novartis Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. Bayer Company Details
Table 113. Bayer Business Overview
Table 114. Bayer Product
Table 115. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 116. Bayer Recent Development
Table 117. Celtaxsys Business Overview
Table 118. Celtaxsys Product
Table 119. Celtaxsys Company Details
Table 120. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 121. Celtaxsys Recent Development
Table 122. Pharmaxis Company Details
Table 123. Pharmaxis Business Overview
Table 124. Pharmaxis Product
Table 125. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 126. Pharmaxis Recent Development
Table 127. ProQR Therapeutics Company Details
Table 128. ProQR Therapeutics Business Overview
Table 129. ProQR Therapeutics Product
Table 130. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 131. ProQR Therapeutics Recent Development
Table 132. PTC Therapeutics Company Details
Table 133. PTC Therapeutics Business Overview
Table 134. PTC Therapeutics Product
Table 135. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 136. PTC Therapeutics Recent Development
Table 137. Alcresta Therapeutics Company Details
Table 138. Alcresta Therapeutics Business Overview
Table 139. Alcresta Therapeutics Product
Table 140. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 141. Alcresta Therapeutics Recent Development
Table 142. Insmed Incorporated Company Details
Table 143. Insmed Incorporated Business Overview
Table 144. Insmed Incorporated Product
Table 145. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 146. Insmed Incorporated Recent Development
Table 147. Savara Company Details
Table 148. Savara Business Overview
Table 149. Savara Product
Table 150. Savara Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 151. Savara Recent Development
Table 152. Cyclacel Pharmaceuticals Company Details
Table 153. Cyclacel Pharmaceuticals Business Overview
Table 154. Cyclacel Pharmaceuticals Product
Table 155. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 156. Cyclacel Pharmaceuticals Recent Development
Table 157. Vectura Company Details
Table 158. Vectura Business Overview
Table 159. Vectura Product
Table 160. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 161. Vectura Recent Development
Table 162. Allergan Company Details
Table 163. Allergan Business Overview
Table 164. Allergan Product
Table 165. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2015-2020) (Million US$)
Table 166. Allergan Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cystic Fibrosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. CFTR Features
Figure 3. Mucolytics Features
Figure 4. PERT Features
Figure 5. Anti-infectives Features
Figure 6. Bronchodilators Features
Figure 7. Global Cystic Fibrosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cystic Fibrosis Therapeutics Report Years Considered
Figure 11. Global Cystic Fibrosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cystic Fibrosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Cystic Fibrosis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cystic Fibrosis Therapeutics Market Share by Players in 2019
Figure 16. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2019
Figure 18. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cystic Fibrosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Vertex Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 27. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 29. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 31. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 35. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 37. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 39. Celtaxsys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 41. Pharmaxis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 43. ProQR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 45. PTC Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 47. Alcresta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 49. Insmed Incorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 51. Savara Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 53. Cyclacel Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 55. Vectura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 57. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2015-2020)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed